The Development of Pancreatic Injury in the Course of Severe Acute Respiratory Syndrome Coronavirus 2 Infection

Uşak University

Status: Completed

Conditions: Pancreatitis

Treatments: Other: biochemical analysis

Study type: Observational

Funder types: Other

Identifiers

NCT04433754

UsakU-Cevdet2

Details and patient eligibility

About

Although COVID-19 disease due to Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) affects the respiratory tract, heart and coagulation system, symptoms of gastrointestinal system involvement such as abdominal pain, nausea, vomiting and diarrhea are also common.

In this study, it was aimed retrospective analysis of clinical and laboratory data of patients who developed pancreatic injury in the course of COVID 19 disease.

Enrollment: 500 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with amylase and lipase levels measured during covid-19 disease with or without pneumonia

Exclusion criteria

• Patients with pregnancy
• Patients whose amylase and lipase levels were not measured during covid 19 disease
• Patients with known solid organ malignacy
• Patients with known hematologic malignacy

Trial design

500 participants in 2 patient groups

patients with pancreatic injury

Description:

patients with higher amylase and lipase levels (higher than the laboratory upper limits) in the course of SARS-CoV-2 infection

Treatment:

Other: biochemical analysis

patients without pancreatic injury

Description:

patients with normal amylase and lipase levels in the course of SARS-CoV-2 infection

Treatment:

Other: biochemical analysis